Embedded Files
June 5, 2026
June 5, 2026
Sonia Bibershtein
Physiotherapy: Summer Sports Modification for Osteoporosis
Objectives:
Review Osteoporosis Canada recommendation for exercise and physical activity
Review general osteoporosis safety precautions
Discuss specific recommendations and modifications for summer sports
Resources:
Upcoming Journal Club dates:
Upcoming Journal Club dates:
2026
TBA
April 24, 2026
April 24, 2026
Adrian Lau, Natasha Gakhal, Sandra Kim
Changes in BMD Testing in Ontario
Objectives:
To review the new policies for BMD testing in Ontario
To discuss opportunities for patient advocacy
Resources:
https://osteoporosis.ca/position-statements/changes-in-bmd-testing-in-ontario-gp/
https://www.ontario.ca/files/2026-03/moh-schedule-benefit-2026-03-27.pdf
February 13, 2026
February 13, 2026
Anny Song
Bone Density Case Discussion
Objectives:
Cases for discussion about interesting bone density cases
Resources:
January 16, 2026
January 16, 2026
Rosario Briones-Urbina
Where do I go from here?
Objectives:
Cases for discussion about which additional interventions should be recommended
Resources:
Nov 7, 2025
Nov 7, 2025
Adrian Lau
OP Fun Rounds & case presentation
Objectives:
To compete in a fun game of bone trivia with friends
Resources:
Oct 10, 2025
Oct 10, 2025
Nicola Berman
Sarcopenia
Objectives:
Understand the causes of sarcopenia and who is at risk
Learn how to assess for sarcopenia presence/severity
Understand prevention and treatment strategies
Understand the association between osteoporosis and sarcopenia
Brief discussion on GLP-1 agonist and the association with sarcopenia
Resources:
Sept 5, 2025
Sept 5, 2025
Natasha Gakhal / Adrian Lau
OP Case Presentation / Use of AI in Osteoporosis Care
Objectives:
To discuss a challenging case in osteoporosis management
To explore the potential use of artificial intelligence in osteoporosis care
Resources:
Previous Presentations
Previous Presentations
June 27, 2025
June 27, 2025
Olexandra Koshkina
Romosozumab and Cardiovascular Safety: What Are We Learning from Real-World Data?
Objectives:
Describe the cardiovascular safety concerns associated with Romosozumab use
Review emerging real-world evidence on the CV safety of Romosozumab
Discuss clinical practice implications based on updated evidence
Resources:
May 2, 2025
May 2, 2025
Sandra Kim
Then Nuances and Hidden Layers of FRAX - How Should we Apply in Clinical Practice?
Objectives:
Review the strengths, shortcomings and clinical nuances of the FRAX model
Discuss how we should adapt in clinical practice
Resources:
March 7, 2025
March 7, 2025
Madison Lamont
Fracture Prevention with Infrequent zoledronate in Women 50 to 60 Years of Age
Objectives:
Summarize Zoledronic acid's existing place in therapy and current literature in early postmenopausal women
Summarize the study's main results, including its impact on bone mineral density, fracture risk, and potential side effects.
Identify the strengths and limitations of the trial
Evaluate how the study's findings align with or challenge existing osteoporosis treatment recommendations
Resources:
Jan 31, 2025
Jan 31, 2025
Adrian Lau
Jubbonti: What physicians and patients need to know
Objectives:
Review what biosimilars are, and how they are approved
Analyze the data comparing Jubbonti and Prolia
Discuss precautions to be aware of, when switching patients from Prolia to Jubbonti
Resources:
Nov 29, 2024
Nov 29, 2024
Adrian Lau
"Fun rounds" - Fun with FRAX
Objectives:
To assess discrepancies when using the FRAX tool to determine a patient's fracture risk
Resources:
Oct 25, 2024
Oct 25, 2024
Adrian Lau
2024 ASBMR Updates
Objectives:
To review relevant clinical updates from the recent ASBMR conference
Resources:
Sept 13, 2024
Sept 13, 2024
Gitta Ankomah
Osteoporosis Patient Education Module
Objectives:
Background on project
Clinic Activities
Progress of QI project
Preview of the slideshow.
Next steps: Discussion and questions
Resources:
June 7, 2024
June 7, 2024
Sonia Bibershtein
Osteoporosis Guideline Recommendations for Exercise and Fall Prevention
Objectives:
Review OP Guidelines Recommendations for Exercise and Fall Prevention
Discuss how guidelines inform exercise recommendations
Discuss other age-related factors that affect falls risk
Resources:
May 3, 2024
May 3, 2024
Alexandra Koshkina
Bone Health in Transgender Patients
Objectives:
Review the role of sex hormones in the development and maintenance of bone health
Discuss changes seen in bone density in trans-gender patients following gender affirming hormone therapy
Review DXA screening goals for transgender patients
Resources:
April 5, 2024
April 5, 2024
Rosario Briones
Anti-resorptive induced hypocalcemia
Objectives:
Review effect of anti-resorptive agents on calcium metabolism
Cases that illustrate pre-disposition to anti-resorptive induced hypocalcemia
Possible strategies to prevent this complication
Resources:
Feb 23, 2024
Feb 23, 2024
Adrian Lau & Natasha Gakhal
Detecting incomplete atypical femur fractures (iAFF) using dual-energy x-ray absorptiometry (DXA)
Objectives:
To review clinical and radiographic characteristics of iAFFs
To discuss ISCD's recommendations on the use of DXA images for screening iAFFs
To consider how WCH can improve iAFF screening
Resources:
Jan 26, 2024
Jan 26, 2024
Anny Song
Precision and LSC in BMD Testing
Objectives:
Use of dual energy x-ray absorptiometry (DXA) in clinical setting
Precision vs. accuracy
ISCD positions related to least significant change (LSC) for monitoring BMD change
Resources:
Dec 1, 2023
Dec 1, 2023
Dr. Adrian Lau
2023 ASBMR Updates
Objectives:
To review relevant clinical updates from the recent ASBMR conference
Resources:
October 27, 2023
October 27, 2023
Drs. Natasha Gakhal, Adrian Lau & Sandra Kim
The 2023 Osteoporosis Canada Guideline (mp4) (slides)
Objectives:
To highlight 10 changes in the current guideline since 2010.
To contrast the 2023 Osteoporosis Canada Guideline to other guidelines, including the 2023 Canadian Task Force on Preventive Health Care Guideline on Fragility Fractures
Resources:
Sept 29, 2023
Sept 29, 2023
Dr. Eleni Dimaraki
Therapy after an atypical femoral fracture (AFF): now what?
Objective:
Understand the risk of atypical femoral fractures and the implications of this diagnosis in patients on osteoporosis therapy.
Review management of patients after recent AFF with focus on medical therapy
Explore options of long-term therapy in patients with high fracture risk who previously had an AFF
June 2, 2023
June 2, 2023
Dr. Alexandra Koshkina
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
Objective:
Review the effectiveness of the available osteoporosis treatments
Discuss the use of risk factors to guide the choice of the initial pharmaotherapy
Resource
April 28, 2023
April 28, 2023
Samantha Guerin
Trending Nutrition Topics in Osteoporosis
Objective:
The gut microbiome and osteoporosis
Getting enough calcium while meeting heart healthy guidelines
Inflammation and dairy milk
March 31, 2023
March 31, 2023
Queenie Wong & Diana Yau
Identifying Incomplete Atypical Femur Fractures using Densitometer
Objective:
Review the definition of Osteoporosis
Discuss the pharmacological therapies used to treat osteoporosis and the possible risks associated with it
Review the ASBMR definition of atypical femur fracture (AFF)
To learn how DXA machines can help in the identification of incomplete AFF (iAFF)
To summarize ISCD official position on early detection of incomplete AFF and clinical applications
Feb 24, 2023
Feb 24, 2023
Dr. Clara Korenvain
Denosumab Discontinuation: the why, when, who and how
Objective:
1. WHY: describe the mechanism behind rebound bone loss following denosumab discontinuation as well as bridging therapy
2. WHEN: explain the expected timeline of rebound bone loss and increased vertebral fracture risk
3. WHO: describe reasons why denosumab discontinuation may be considered and who is at risk of rebound bone loss
4. HOW: justify strategies for minimizing rebound bone loss following denosumab discontinuation
Resources: slides from presentation
Jan 27, 2023
Jan 27, 2023
Dr. Tehmina Ahmad
A Critical Appraisal of the "TERABIT Study"
Objective:
To critically appraise the Terabit Study using CASP (Critical Appraisl Skills Programme) for Randomized Control Trials
Report the results and application of the Terabit study to our OP population
Resources:
Dec 2, 2022
Dec 2, 2022
Larry Funnell
Breaking the Cycle of Recurrent Fractures
Objective:
To learn the importance of patient engagement in the research and development of policies and guidelines for the management of osteoporosis from the perspective of long-time volunteer and men’s health advocate with Osteoporosis Canada
October 28, 2022
October 28, 2022
Adrian Lau & Natasha Gakhal
Interesting cases from the ISCD BMD Atlas/ plus an additional challenging case
Objective:
To review and discuss various cases featuring images from bone mineral density testing.
To review resources available through the International Society of Clinical Densitometry (ISCD)
Resources:
Sept 30, 2022
Sept 30, 2022
Adrian Lau
2022 ASBMR Updates
Objective:
To review relevant clinical updates from the recent ASBMR conference
Resources:
June 3, 2022
June 3, 2022
Adrian Lau
A review of FGF-23
Objective
To review the physiologic actions of FGF-23
To discuss disorders related to FGF-23
To explore treatment options for FGF-23 related disorders
May 6, 2022
May 6, 2022
Clara Korenvain
Romosozumab – who is it good for?
Objective
Define the target population and optimal place in therapy for romosozumab treatment
Evaluate the cardiovascular/stroke risks of romosozumab
Resources:
April 1, 2022
April 1, 2022
Sonia Bibershtein
Physiotherapy and Osteoporosis: An Update
Objective
To review an adapted clinical practice guidelines for the management of osteoporosis that focuses on interventions to maintain bone mass in premenopausal women, postmenopausal women, and men.
Update on physiotherapy interventions for falls prevention strategies.
Resources:
February 25, 2022
February 25, 2022
Anita Colquhoun & Harpreet Gill
Highlights from the ISCD 2021 Virtual Annual Meeting
Objective
Osteoporosis in the Era of COVID-19
Describe the impact of COVID-19 in Osteoporosis
ISCD Positions You Can Use - Now!
Understand the applicability of some of the new positions from the 2019 PDC
Trabecular Bone Score (TBS) Overview
Outline how TBS is calculated and the benefit of using TBS
Using FRAX Wisely
Better understand how FRAX is used in clinical practice
Resources:
January 28, 2022
January 28, 2022
Dr. Elizabeth Grigoriadis
It's only psoriasis... Do topical steroids and psoriasis increase fracture risk?
Objective
Review the impact of potent topical corticosteroid therapy on fracture risk
Review mechanism of GIOP and inflammation causing bone loss
Review the impact of psoriasis on fracture risk
Resources:
December 3, 2021
December 3, 2021
Dr. Miranda Boggild
Alternative Options for Bisphosphonates
Objective
Review the evidence for bisphosphonates in bony pain management
Discuss the role of bisphosphonates in avascular necrosis of the bone
October 29, 2021
October 29, 2021
Dr. Adrian Lau
ASBMR Updates
Objective
To review relevant clinical updates from the recent virtual ASBMR conference
Resources:
September 24, 2021
September 24, 2021
Dr. Alexandra Koshkina
Knowledge and Needs of Resident Physicians Regarding Osteoporosis
Knowledge and Needs of Resident Physicians Regarding Osteoporosis
Objectives
Review the study on residents' knowledge and comfort in treating osteoporosis
Discuss ways to improve resident education in the area of osteoporosis
July 30, 2021
July 30, 2021
Dr. Adrian Lau
The Impact of Stress on Bone Health
The Impact of Stress on Bone Health
Objectives
To examine the evidence of how stress may impact bone health and fracture risk
To review how stress induced lifestyle changes may affect bone health
To explore the impact of stress lowering strategies on bone health
June 4, 2021
June 4, 2021
Dr. Anuj Bhatia
Update on Vertebroplasty at WCH
Update on Vertebroplasty at WCH
Objectives
To discuss the experience with referral and management of patients needing vertebroplasty at WCH
To discuss key steps in the referral and follow-up process
To present the proposed patient information document for vertebroplasty
March 26, 2021
March 26, 2021
Dr. Alexandra Koshkina
Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis
Objectives
Review current knowledge on use of romosozumab for treatment of postmenopausal osteoporosis
Compare the effects of prior osteoporosis treatment on response to romosozumab in terms of BMD and bone-turnover markers
Discuss applicability of the study findings to clinical practice
February 26, 2021
February 26, 2021
Dr. Sahil Koppikar
Too Early to Fracture: Osteoporosis in Premenopausal Women
Objectives
Discuss a case of premenopausal osteoporosis
Review factors affecting bone mass and causes of premenopausal osteoporosis
Discuss treatment principles with a focus on evidence for teriparatide in premenopausal idiopathic osteoporosis
January 29, 2021
January 29, 2021
Dr. Rosario Briones-Urbina
A case of adult genetic hypophosphatasia
Objectives
Review the diverse clinical presentations of this condition
Understand the physiology and the implications for management
Discuss treatment strategies
November 27, 2020
November 27, 2020
Dr. Sandra Kim
Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomized controlled trials: Article Discussion
Objectives
To understand the rationale of using bone density as a surrogate for fracture
To appreciate the value and shortcomings of using pooled individual patient data to determine treatment effect explained by bone density changes observed from RCTs
To discuss future implications of using bone density as a surrogate for fracture in clinical practice
October 30, 2020
October 30, 2020
Dr. Natasha Gakhal
Update on Atypical Femur Fractures
Objective
Review history of atypical femur fractures in the context of osteoporosis treatment
Review NEJM article by Black, D et al on atypical femur fractures from Aug 2020
What does the NEJM article add to the current knowledge of atypical femur fractures?
Implications of NEJM article for clinical practice
September 25, 2020
September 25, 2020
Dr. Adrian Lau
ASBMR Updates
Objective
To review relevant clinical updates from the recent virtual ASBMR conference
Resources:
August 28, 2020
August 28, 2020
Dr. Jill Pancer
Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial
Objectives
To understand the rationale behind sequential therapy using anti-resorptive and anabolic agents.
To compare changes in bone density and bone turnover markers using a standard sequence of treatment with teriparatide followed by denosumab versus a cyclic regimen.
To discuss the applicability of a cyclic regimen to routine clinical practice.
July 31, 2020
July 31, 2020
Dr. Savannah Cardew
Effect of dietary calcium on bone density
June 26, 2020
June 26, 2020
Dr. Adrian Lau
Page updated
Google Sites
Report abuse